FinTrust Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $201 | Sell |
3
-73
| -96% | -$4.89K | ﹤0.01% | 1331 |
|
|
2024
Q2 | $9.03K | Buy |
76
+27
| +55% | +$3.21K | ﹤0.01% | 898 |
|
|
2024
Q1 | $5.22K | Hold |
49
| – | – | ﹤0.01% | 964 |
|
|
2023
Q4 | $4.87K | Sell |
49
-125
| -72% | -$12.4K | ﹤0.01% | 943 |
|
|
2023
Q3 | $18K | Buy |
174
+111
| +176% | +$11.5K | ﹤0.01% | 670 |
|
|
2023
Q2 | $11.3K | Hold |
63
| – | – | ﹤0.01% | 741 |
|
|
2023
Q1 | $11.3K | Hold |
63
| – | – | ﹤0.01% | 740 |
|
|
2022
Q4 | $11.3K | Hold |
63
| – | – | ﹤0.01% | 740 |
|
|
2022
Q3 | $8K | Sell |
63
-125
| -66% | -$15.9K | ﹤0.01% | 931 |
|
|
2022
Q2 | $31K | Buy |
188
+166
| +755% | +$27.4K | 0.01% | 620 |
|
|
2022
Q1 | $4K | Sell |
22
-105
| -83% | -$19.1K | ﹤0.01% | 1095 |
|
|
2021
Q4 | $32K | Sell |
127
-184
| -59% | -$46.4K | 0.01% | 621 |
|
|
2021
Q3 | $120K | Buy |
311
+17
| +6% | +$6.56K | 0.03% | 367 |
|
|
2021
Q2 | $69K | Hold |
294
| – | – | 0.02% | 498 |
|
|
2021
Q1 | $38K | Sell |
294
-100
| -25% | -$12.9K | 0.01% | 572 |
|
|
2020
Q4 | $41K | Buy |
394
+194
| +97% | +$20.2K | 0.01% | 525 |
|
|
2020
Q3 | $14 | Buy |
200
+46
| +30% | +$3 | ﹤0.01% | 716 |
|
|
2020
Q2 | $10K | Buy |
154
+19
| +14% | +$1.23K | ﹤0.01% | 722 |
|
|
2020
Q1 | $4K | Buy |
+135
| New | +$4K | ﹤0.01% | 905 |
|